Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Seattle Gummy Company focuses its patent efforts in the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action. This action is handled by a distinct examiner, which indicates a high level of concentration in the prosecution process. This workload is contained within a distinct art unit, suggesting a narrow technical focus for the pending application.
The busiest examiner assigned to this case is HOERNER, PAUL ELLSWORTH. This examiner is responsible for 1 busiest examiner pending office action. Because the total number of pending office actions is limited, this individual is managing all active matters for the company. The Biotechnology & Pharmaceuticals designation implies that the subject matter involves specialized medical or biological research.
For the practitioner, having a single examiner and art unit means that the prosecution strategy can be highly tailored. The influence of HOERNER, PAUL ELLSWORTH is central to the success of the portfolio. Since the pending office action is in a specific art unit, the company can expect consistent application of examination guidelines. This streamlined structure simplifies the management of the active filing.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOERNER, PAUL ELLSWORTH | 1 | 50.0% | +62.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039272 | STABLE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | HOERNER, PAUL ELLSWORTH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039272 | STABLE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | HOERNER, PAUL ELLSWORTH | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039272 | STABLE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | HOERNER, PAUL ELLSWORTH | 1611 | §103§112 | Non-Final OA | — | Pending | May 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial